1. Home
  2. ATGL vs RLMD Comparison

ATGL vs RLMD Comparison

Compare ATGL & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

HOLD

Current Price

$23.50

Market Cap

275.7M

Sector

N/A

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

307.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATGL
RLMD
Founded
2017
2004
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.7M
307.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ATGL
RLMD
Price
$23.50
$4.08
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
64.2K
1.1M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,206,460.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.36
N/A
52 Week Low
$9.01
$0.24
52 Week High
$57.32
$5.12

Technical Indicators

Market Signals
Indicator
ATGL
RLMD
Relative Strength Index (RSI) 53.00 56.92
Support Level $24.01 $3.95
Resistance Level $26.20 $4.72
Average True Range (ATR) 2.79 0.44
MACD 0.10 -0.08
Stochastic Oscillator 43.16 38.84

Price Performance

Historical Comparison
ATGL
RLMD

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: